Sakar Healthcare scheduled board meeting on 12th May 2026 to approve audited FY25-26 standalone and consolidated financial results.
Trading window remains closed for designated persons until 48 hours after results declaration per insider trading regulations.
Regulatory compliance disclosure submitted to NSE under SEBI LODR Regulation 29 requirements.